MACKENZIE DOSHI: Open Payments
NPI 1588021257 · EDGEWATER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,065 in 171 payments from 20 companies in 2025. Trend: 2023 $2,985 · 2024 $3,983 · 2025 $4,065
Food & beverage: $3,965Education: $100
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $482 |
| Janssen Biotech, Inc. | 13 | $364 |
| ABBVIE INC. | 14 | $326 |
| Lilly USA, LLC | 7 | $320 |
| Novartis Pharmaceuticals Corporation | 15 | $320 |
| E.R. Squibb & Sons, L.L.C. | 11 | $312 |
| Organon LLC | 29 | $312 |
| UCB, Inc. | 10 | $288 |
| Incyte Corporation | 16 | $280 |
| Regeneron Healthcare Solutions, Inc. | 8 | $245 |
Products named: DUPIXENT, TREMFYA, Sotyktu, Bimzelx, OPZELURA, TALTZ, COSENTYX, SKYRIZI.
Industry payments across MD — which companies pay providers there.
